NO20001415L - Farmasøytikum inneholdende vitamin-K-avhengige faktorer - Google Patents

Farmasøytikum inneholdende vitamin-K-avhengige faktorer

Info

Publication number
NO20001415L
NO20001415L NO20001415A NO20001415A NO20001415L NO 20001415 L NO20001415 L NO 20001415L NO 20001415 A NO20001415 A NO 20001415A NO 20001415 A NO20001415 A NO 20001415A NO 20001415 L NO20001415 L NO 20001415L
Authority
NO
Norway
Prior art keywords
containing vitamin
pharmaceuticals containing
dependent factors
dependent
factors
Prior art date
Application number
NO20001415A
Other languages
English (en)
Norwegian (no)
Other versions
NO20001415D0 (no
Inventor
Yendra Linnau
Peter Turecek
Hans-Peter Schwarz
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Ag filed Critical Baxter Ag
Publication of NO20001415D0 publication Critical patent/NO20001415D0/no
Publication of NO20001415L publication Critical patent/NO20001415L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
NO20001415A 1997-09-19 2000-03-17 Farmasøytikum inneholdende vitamin-K-avhengige faktorer NO20001415L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0159197A AT409334B (de) 1997-09-19 1997-09-19 Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren
PCT/AT1998/000224 WO1999015196A1 (de) 1997-09-19 1998-09-17 Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren

Publications (2)

Publication Number Publication Date
NO20001415D0 NO20001415D0 (no) 2000-03-17
NO20001415L true NO20001415L (no) 2000-05-19

Family

ID=3516739

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001415A NO20001415L (no) 1997-09-19 2000-03-17 Farmasøytikum inneholdende vitamin-K-avhengige faktorer

Country Status (10)

Country Link
EP (1) EP1015020A1 (de)
JP (1) JP2001517636A (de)
AT (1) AT409334B (de)
AU (1) AU743102B2 (de)
BR (1) BR9812222A (de)
CA (1) CA2304396A1 (de)
HU (1) HUP0003681A1 (de)
NO (1) NO20001415L (de)
SK (1) SK4022000A3 (de)
WO (1) WO1999015196A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2357751C2 (ru) 2001-12-21 2009-06-10 Ново Нордиск Хелт Кэр Аг Жидкая композиция полипептидов фактора vii
AU2003213146A1 (en) * 2002-03-08 2003-09-22 Eli Lilly And Company Activated protein c formulations
EP2283856B1 (de) 2002-06-21 2017-09-20 Novo Nordisk Health Care AG Stabiliserte feste Zusammensetzungen von Faktor VIIa Polypeptiden
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
DE602004025100D1 (de) 2003-05-23 2010-03-04 Novo Nordisk Healthcare Ag Stabilisierung von proteinen in lösung
ES2382157T3 (es) 2003-06-25 2012-06-05 Novo Nordisk Health Care Ag Composición líquida de polipépttidos del factor VII
ES2574581T3 (es) 2003-08-14 2016-06-20 Novo Nordisk Health Care Ag Composición farmacéutica líquida acuosa de polipéptidos de tipo Factor VII
AU2004298789A1 (en) 2003-12-19 2005-06-30 Novo Nordisk Health Care Ag Stabilised compositions of factor VII polypeptides
JP2008530208A (ja) * 2005-02-16 2008-08-07 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ 万能前凝固薬
JP2008531692A (ja) 2005-03-04 2008-08-14 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ 凝固及び線維素溶解カスケードのモジュレーター
WO2009046194A2 (en) 2007-10-05 2009-04-09 The Board Of Trustees Of The University Of Illinois Fibrin sealant
US20100297257A1 (en) 2007-11-09 2010-11-25 National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs) Anticoagulant antagonist and hemophillia procoagulant
KR20130136988A (ko) * 2010-10-06 2013-12-13 메디뮨 리미티드 지혈 장애를 치료하기 위한 인자 ii 및 피브리노겐
EP3579857B1 (de) * 2017-02-09 2022-04-06 CSL Behring GmbH Blutgerinnungsfaktorersatzprodukt zur verwendung bei der behandlung oder prophylaxe von blutungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8729822D0 (en) * 1987-12-22 1988-02-03 Central Blood Lab Authority Chemical process
IT1262899B (it) * 1992-03-27 1996-07-22 Sclavo Spa Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
DE4342132C1 (de) * 1993-12-10 1994-11-03 Octapharma Ag Verfahren zur Herstellung virusinaktivierte Vitamin K abhängige Plasmakomponenten sowie Protein C und Protein S enthaltender Mittel durch Membran-Chromatographie
DE4430205A1 (de) * 1994-08-26 1996-02-29 Behringwerke Ag Zusammensetzungen, die als Gegenmittel für Blut-Antikoagulanzien geeignet sind und deren Verwendung
ATE296109T1 (de) * 1996-03-20 2005-06-15 Baxter Ag Pharmazeutisches präparat zur behandlung von blutgerinnungsstörungen

Also Published As

Publication number Publication date
HUP0003681A1 (hu) 2001-02-28
SK4022000A3 (en) 2000-09-12
EP1015020A1 (de) 2000-07-05
AU9244998A (en) 1999-04-12
CA2304396A1 (en) 1999-04-01
NO20001415D0 (no) 2000-03-17
AT409334B (de) 2002-07-25
AU743102B2 (en) 2002-01-17
JP2001517636A (ja) 2001-10-09
ATA159197A (de) 2001-12-15
WO1999015196A1 (de) 1999-04-01
BR9812222A (pt) 2000-07-18

Similar Documents

Publication Publication Date Title
CO5060503A1 (es) Formulaciones farmaceuticas
NO20001415L (no) Farmasøytikum inneholdende vitamin-K-avhengige faktorer
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
PT83872A (de) Arzneimittel
NO20002217L (no) Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler
DZ1966A1 (fr) Combinaison pharmaceutique nouvelle.
ATE304351T1 (de) Arzneizubereitungen enthaltend kannabinoide
NO307459B1 (no) Piperazinderivater, samt farmasøytiske preparater inneholdende slike
FI853913A (fi) Farmaceutiska foereningar som antracyklinglykosider.
FI861532A0 (fi) Foerfarande foer att insamla uppgifter som en brand, branddetektor som utnyttjar detta foerfarande och brandalarmsystem som likasao utnyttjar detta foerfarande.
NO901657D0 (no) Fuktende baeremiddel for topisk administrering av vitamin a syre.
TR199700415A3 (tr) D3 vitamini analoglari.
ES2160410T3 (es) Preparados de complejos de protrombina inmunotolerantes.
IS4774A (is) Lyfjafræðilegar samsetningar með D-vítamín hliðstæðum
ES2193539T3 (es) Benzonaftiridinas.
AU8910698A (en) Alkali metal hybrid spin-exchange optical pumping
MX9603606A (es) N-metil-n-[(1s)-1-fenil-2-((3s)-3-hidroxipirrolidin-1-il) etil]-2,2-difenil-acetamida.
NO974934L (no) 10,13,15-trioksatrisyklo£9.2.1.19.6|pentadekanonderivater, fremgangsmÕte for deres fremstilling og legemidler som inneholder disse forbindelsene
FI884545A0 (fi) Farmaceutisk komposition, som innehaoller avsvaellande piperidinoalkanolfoereningar.
FI905640A0 (fi) Foerfarande foer blekning av traemassa med basisk peroxid med anvaendande av kvaternaer amin som tillsatsaemne.
IT1191255B (it) Composizione farmaceutiche a base di alcaloidi della segale cornuta 9,10-diidrogenati
FI883912A (fi) Centrifugalpumphjul och saett vid pumpning av en vaetska, som innehaoller gas, medelst en centrifugalpump.
DK1001942T3 (da) Polyhydroxybutylpyraziner, deres fremstilling samt medikamenter indeholdende disse forbindelser
LV10870A (lv) Jauni fosfolipidu atvasinajumi
FI894072A (fi) Polypeptider anvaendbara som vaccin.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application